Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages, according to new calculations released by Cancer Research UK today.
Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages, according to new calculations released by Cancer Research UK today.
The faecal immunochemical test (FIT) is now an established bowel cancer test. This diagnostic assay identifies the presence of hidden blood in the stool, known as faecal occult blood (FOB), which can be an early sign of colorectal cancer. FIT uses antibodies specific to human haemoglobin so is more accurate and sensitive, provides a quantitative measurement and gives fewer false positive results than other tests.
Read MoreNICE DG56 vs. NICE DG30 March 21, 2024
A New Portal to Ef-FIT-ciency June 16, 2023
Partnership with the NHS Award Winners! December 7, 2021
Trade-In Your Old #Pipettes & Save up to 40%
Protect your hands from strain & improve your liquid handling reproducibility all while receiving 40% off a brand new Proline Plus Pipette & 35% off Tacta manual or Picus 2 electronic pipettes
View the Offer: https://www.alphalabs.co.uk/current-special-offers/laboratory-products-special-offers/pipette-trade-in-offer-save-up-to-40
New LabVantage Out Now!
Explore our latest innovations and eco-friendly products. Plus Exclusive Offers:
- Up to 40% off Sartorius Pipettes
- 33% off Microdispensers
- 20% off New Rigid PCR Plates
- 35% off Cryoboxes
Explore LabVantage And All Offers: https://files.alphalabs.co.uk/e-mags/LabVantage-2024-2/